ILD is interesting to find prognostic factors. Initial CRP, reflecting IL-6 production, appears as an important prognostic factor for FVC evolution overtime. Conversely, SSc and autoantibodies subtypes were not prognostic factors for PFTs evolution in our study. ILD extension is associated with worse PFTs at baseline but is not associated with DLCO of FVC decline. References
BACKGROUND: Acute/subacute interstitial pneumonia in dermatomyositis (DM-A/SIP) is a disease associa...
erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis. Eur J Dermatol ...
Recent studies have suggested that neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein-to-al...
Objective. Soluble CD206 (sCD206) is considered a macrophage activation marker, and a previous study...
Background: Rapidly progressive interstitial lung disease (RP-ILD) is a fatal complication of dermat...
SummaryBackgroundPolymyositis and dermatomyositis-associated interstitial lung disease (PM/DM-ILD) c...
Acute/subacute interstitial pneumonia in dermatomyositis (DM-A/SIP) is a disease associated with a p...
Abstract Background This study aimed to describe the clinical characteristics and analyze the poor p...
Objective. Antimelanoma differentiation-associated protein 5 (anti-MDA5) autoantibody has been repor...
Background: Acute/subacute interstitial pneumonia in dermatomyositis (DM-A/SIP) is a disease associa...
Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM), dermatomyositis (DM)...
To investigate the characteristics of organ involvement and immunological markers in dermatomyositis...
Abstract Background Interstitial lung disease (ILD) is the principal cause of death in polymyositis/...
Objective S100A12 is an emerging inflammatory disease biomarker. Interstitial lung disease (ILD) is ...
Interstitial lung disease (ILD) is an extramuscular manifestation that results in increased morbidit...
BACKGROUND: Acute/subacute interstitial pneumonia in dermatomyositis (DM-A/SIP) is a disease associa...
erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis. Eur J Dermatol ...
Recent studies have suggested that neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein-to-al...
Objective. Soluble CD206 (sCD206) is considered a macrophage activation marker, and a previous study...
Background: Rapidly progressive interstitial lung disease (RP-ILD) is a fatal complication of dermat...
SummaryBackgroundPolymyositis and dermatomyositis-associated interstitial lung disease (PM/DM-ILD) c...
Acute/subacute interstitial pneumonia in dermatomyositis (DM-A/SIP) is a disease associated with a p...
Abstract Background This study aimed to describe the clinical characteristics and analyze the poor p...
Objective. Antimelanoma differentiation-associated protein 5 (anti-MDA5) autoantibody has been repor...
Background: Acute/subacute interstitial pneumonia in dermatomyositis (DM-A/SIP) is a disease associa...
Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM), dermatomyositis (DM)...
To investigate the characteristics of organ involvement and immunological markers in dermatomyositis...
Abstract Background Interstitial lung disease (ILD) is the principal cause of death in polymyositis/...
Objective S100A12 is an emerging inflammatory disease biomarker. Interstitial lung disease (ILD) is ...
Interstitial lung disease (ILD) is an extramuscular manifestation that results in increased morbidit...
BACKGROUND: Acute/subacute interstitial pneumonia in dermatomyositis (DM-A/SIP) is a disease associa...
erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis. Eur J Dermatol ...
Recent studies have suggested that neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein-to-al...